Muna Therapeutics ApS — Credit Rating and Financial Key Figures

Muna Therapeutics ApS (CVR number: 41142871) is a company from FREDERIKSBERG. The company recorded a gross profit of -110624.4 kDKK in 2023. The operating profit was -142.5 mDKK, while net earnings were -140.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -69.8 %, which can be considered poor and Return on Equity (ROE) was -85.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 75.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Muna Therapeutics ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.